⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for neoplasms, bladder

Every month we try and update this database with for neoplasms, bladder cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.NCT03335059
Bladder Cancer
Bladder Neoplas...
Bladder Tumors
Cancer of Bladd...
Cancer of the B...
Malignant Tumor...
Neoplasms, Blad...
Urinary Bladder...
Carcinoma in Si...
Papillary Carci...
BCG-Unresponsiv...
Synergo® RITE +...
18 Years - Medical Enterprises Ltd.
Study of ESG401 in Adults With Solid TumorsNCT04892342
Neoplasms, Brea...
Neoplasms, Lung
Neoplasms,Color...
Neoplasms, Blad...
Neoplasm of Sto...
Neoplasms,Ovari...
ESG401
18 Years - 75 YearsShanghai Escugen Biotechnology Co., Ltd
A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder CancerNCT05699135
Urinary Bladder...
Bladder Cancer
Bladder Tumors
Urothelial Carc...
Avelumab first-...
18 Years - Pfizer
A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder CancerNCT05699135
Urinary Bladder...
Bladder Cancer
Bladder Tumors
Urothelial Carc...
Avelumab first-...
18 Years - Pfizer
Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.NCT03335059
Bladder Cancer
Bladder Neoplas...
Bladder Tumors
Cancer of Bladd...
Cancer of the B...
Malignant Tumor...
Neoplasms, Blad...
Urinary Bladder...
Carcinoma in Si...
Papillary Carci...
BCG-Unresponsiv...
Synergo® RITE +...
18 Years - Medical Enterprises Ltd.
Survivin Urine mRNA Assay Risk of Bladder Cancer StudyNCT00315653
Bladder Cancer
50 Years - Fujirebio Diagnostics, Inc.
Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder CancerNCT05072600
Bladder Cancer
Bladder Neoplas...
Bladder Tumors
Urinary Bladder...
Neoplasms, Blad...
Pembrolizumab
18 Years - Peking University First Hospital
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: